. Author manuscript; available in PMC: 2016 Feb 5.

Published in final edited form as: J Sex Med. 2013 Apr 3;10(6):1636–1643. doi: 10.1111/jsm.12135

Table 2.

Percent achieving back to baseline erectile function recovery

		With/without PDE5i at 24 months	95% CI	Not using PDE5i at 24 months	95% CI
Total sample	N = 180	43%	36–51%	22%	16–24%
Baseline EFD ≥ 24	N = 132	36%	28–44%	16%	11–23%

EFD = Erectile Function Domain; PDE5i = phosphodiesterase type 5 inhibitor